ABUS vs MU · P/E 5.4, rev $6.2M vs P/E 21, rev $37.38B
Arbutus Biopharma Corp (ABUS) versus Micron Technology Inc (MU) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Micron Technology Inc (MU) is a semiconductors company listed on US. It is led by Sanjay Mehrotra.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MU revenue for 2025-08-28 was $37.38B. Net income was $8.54B. MU currently screens at market cap $187.25B and trailing P/E 20.7.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MU currently screens at market cap $187.25B and trailing P/E 20.7.
Not investment advice. Open the ABUS and MU stock pages for the full models.
Not investment advice.